Iovance Biotherapeutics I... (IOVA)

AI Score

Unlock

3.54

0.29 (8.92%)

At close: Apr 02, 2025, 3:59 PM

3.33

-6.08%

Pre-market: Apr 03, 2025, 08:55 AM EDT

Iovance Biotherapeutics Balance Sheet Statement

Chart Mode

Financials in USD. Fiscal year is January - December.

Fiscal Year	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020	FY 2019	FY 2018	FY 2017	FY 2016	FY 2015	FY 2014	FY 2013	FY 2012	FY 2011	FY 2010	FY 2009	FY 2008
Period Ending	Dec 31, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021	Dec 31, 2020	Dec 31, 2019	Dec 31, 2018	Dec 31, 2017	Dec 31, 2016	Dec 31, 2015	Dec 31, 2014	Dec 31, 2013	Dec 31, 2012	Dec 31, 2011	Dec 31, 2010	Dec 31, 2009	Dec 31, 2008
Cash & Equivalents	115.69M	114.89M	231.73M	78.23M	67.33M	13.97M	82.15M	145.37M	166.47M	103.7M	44.91M	19.67M	-5K	510.22K	1.3M	8.26K	2.9K
Short-Term Investments	208.09M	164.98M	240.11M	426.18M	562.11M	293.11M	386.37M	n/a	59.75M	90.06M	n/a	n/a	5K	9.39K	n/a	n/a	n/a
Long-Term Investments	n/a	n/a	6.43M	91.59M	5.53M	5.45M	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a
Other Long-Term Assets	6.73M	66.7M	-178.25M	7.87M	12.92M	7.44M	2.76M	3.63M	n/a	n/a	n/a	n/a	-22.14K	16K	-160.04K	n/a	n/a
Receivables	69.34M	151K	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a
Inventory	51.52M	10.37M	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a
Other Current Assets	12.38M	17.46M	7.27M	3.55M	6.66M	9.41M	6.85M	3.92M	3.04M	277K	66.13K	n/a	2.27K	n/a	n/a	150.00	n/a
Total Current Assets	457.02M	307.85M	471.85M	507.96M	636.1M	312.53M	475.37M	149.29M	169.51M	103.98M	44.98M	19.85M	7.28K	524.08K	1.3M	8.41K	3.06K
Property-Plant & Equipment	164.28M	176.54M	178.25M	169.92M	113.92M	19.23M	2.68M	2.45M	2.37M	1.68M	1.53M	27.76K	22.14K	28.35K	160.04K	n/a	2.56K
Goodwill & Intangibles	282.4M	229.26M	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	160.04K	1.23K	n/a
Total Long-Term Assets	453.41M	472.5M	6.43M	269.38M	132.36M	32.12M	5.45M	6.08M	2.37M	1.68M	1.53M	27.76K	22.14K	44.35K	160.04K	1.23K	2.56K
Total Assets	910.43M	780.35M	663.98M	777.33M	768.46M	344.65M	480.82M	155.37M	171.89M	105.65M	46.51M	19.87M	29.41K	568.43K	1.46M	9.63K	5.61K
Account Payables	27.51M	33.12M	26.6M	27.38M	13.51M	15.57M	2.74M	1.23M	863K	958K	1.25M	412.98K	1.1M	190.05K	30.29K	n/a	n/a
Deferred Revenue	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	221.51K	n/a	n/a	n/a
Short-Term Debt	12.9M	n/a	12.59M	5.06M	6.28M	7.25M	n/a	n/a	n/a	n/a	n/a	n/a	6.48M	5M	n/a	n/a	n/a
Other Current Liabilities	81.94M	34.59M	20.3M	30.2M	19.76M	2.15M	7.55M	5.75M	2.52M	24K	242.26K	338.73K	n/a	7.94M	792.58K	n/a	3.32K
Total Current Liabilities	122.34M	110.31M	91.48M	89.2M	54.87M	39.08M	14.4M	9.89M	4.97M	1.63M	1.66M	2.27M	11.35M	13.35M	822.87K	23.12K	3.33K
Long-Term Debt	44.37M	1M	1M	1M	45.38M	4.25M	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a
Other Long-Term Liabilities	1M	n/a	n/a	n/a	-33.66M	-1.9M	230K	297K	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a
Total Long-Term Liabilities	77.68M	85.43M	84.45M	66.47M	57.09M	6.6M	230K	297K	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a
Total Liabilities	200.02M	195.74M	164.34M	155.67M	111.96M	45.68M	14.63M	9.89M	4.97M	1.63M	1.66M	2.27M	11.35M	13.35M	822.87K	23.12K	3.33K
Total Debt	57.26M	75.86M	84.45M	71.53M	51.66M	11.5M	n/a	n/a	n/a	n/a	n/a	n/a	6.48M	5M	n/a	n/a	n/a
Common Stock	13K	11K	8K	7K	6K	5K	5K	3K	3K	2K	1.41K	835.00	3.41K	3.25K	3.07K	5.06K	5.06K
Retained Earnings	-2.38B	-2.01B	-1.57B	-1.17B	-830.19M	-570.61M	-372.76M	-249.18M	-157.12M	-104.22M	-76.56M	-64.53M	-30.68M	-27.38M	-1.68M	-74.49K	-58.72K
Comprehensive Income	-1.05M	2.53M	-902K	-601K	19K	220K	-42K	n/a	29K	48K	-104.22K	-16K	-8.91K	-2.7K	n/a	n/a	n/a
Shareholders Equity	710.4M	584.61M	499.64M	621.66M	656.5M	298.97M	466.19M	145.48M	166.92M	104.02M	44.85M	17.6M	-11.32M	-12.78M	638.09K	-13.49K	2.28K
Total Investments	208.09M	164.98M	240.11M	517.77M	562.11M	293.11M	386.37M	n/a	59.75M	90.06M	n/a	n/a	5K	9.39K	n/a	n/a	n/a